Table 1.
Clinical and laboratory characteristics of study groups
| Non-fatty pancreas (n = 113) | Fatty pancreas (n = 180) | P-value | |
| Age (yr) | 44.4 ± 9.7 | 45.4 ± 8.5 | NS |
| Sex (male/female) | 34/79 | 93/87 | < 0.001 |
| BMI (kg/m2) | 24.4 ± 3.2 | 26.5 ± 3.1 | < 0.001 |
| WC (cm) | 82.1 ± 9.3 | 88.9 ± 8.5 | < 0.001 |
| Visceral Fat(mm2) | 7462 ± 3244 | 10767 ± 4260 | < 0.001 |
| AST (IU/L) | 23.8 ± 11.1 | 30.2 ± 20.7 | 0.001 |
| ALT (IU/L) | 25.0 ± 23.0 | 40.3 ± 32.2 | < 0.001 |
| FBS (mg/dL) | 99.7 ± 24.0 | 102.9 ± 26.2 | NS |
| TC (mg/dL) | 192.9 ± 36.4 | 205.2 ± 35.2 | 0.005 |
| TG (mg/dL) | 119.6 ± 70.3 | 159.8 ± 92.5 | < 0.001 |
| LDL (mg/dL) | 118.6 ± 36.3 | 124.8 ± 27.4 | NS |
| HDL (mg/dL) | 51.9 ± 10.1 | 47.7 ± 10.6 | 0.001 |
| γ-GT (mg/dL) | 29.9 ± 29.9 | 46.5 ± 43.0 | < 0.001 |
| Fasting insulin (μU/mL) | 5.4 ± 2.1 | 6.8 ± 3.6 | < 0.001 |
| HOMR-IR | 2.3 ± 1.0 | 3.2 ± 2.1 | < 0.001 |
| FFA (mg/dL) | 639.3 ± 287.6 | 767.9 ± 324.9 | 0.001 |
P < 0.05 by t-test; NS: Not significant; BMI: Body mass index; WC: Waist circumference; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; FBS: Fasting blood sugar; TC: Total cholesterol; TG: Triglyceride; HDL: High density lipoprotein cholesterol; LDL: Low density lipoprotein cholesterol; γ-GT: Gamma glutamyl transpeptidase; FFA: Free fatty acid.